Vident Advisory, LLC Eli Lilly & CO Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vident Advisory, LLC holds 19,531 shares of LLY stock, worth $17.3 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
19,531
Previous 18,651
4.72%
Holding current value
$17.3 Million
Previous $14.5 Billion
21.86%
% of portfolio
0.49%
Previous 0.3%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
3,871Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$85.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$65.5 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$58.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$45.6 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $843B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...